PPCB Stock Analysis: Buy, Sell, or Hold?
PPCB - Propanc Biopharma, Inc. Common Stock
$1.47
-0.01 (-0.68%)
▼
5d:
-31.63%
30d:
-15.03%
90d:
+1147.88%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When PPCB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: PPCB is down 31.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: PPCB is down 31.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: PPCB is currently trading at $1.47, which is considered slightly low relative to its 30-day fair value range of $1.47 to $2.02.
Technical Outlook: Technically, PPCB is in a uptrend. Immediate support is located at $1.31, while resistance sits at $1.98.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PPCB is in a uptrend. Immediate support is located at $1.31, while resistance sits at $1.98.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.47 -
$2.02
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($1.52)
- WARNING: Recommendation downgraded due to -31.6% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.47 -
$2.02
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.31
Resistance Level
$1.98
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$1.52
(+3.4%)
Share & Embed Analysis
Last updated: June 24, 2026 2:28 AM ET
Data refreshes hourly during market hours. Next update: 3:28 AM
Data refreshes hourly during market hours. Next update: 3:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PPCB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 54 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 67 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 59 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |